Do ACE inhibitors have antiarrhythmic properties?
Part 3: Overview of study designs
Inflammatory markers and the risk of coronary heart disease
Statin therapy in heart failure
Inflammatory markers versus lipid levels in the risk of CAD
ACE inhibition and atrial fibrillation: Improving the substrate
A hypertensive patient with atrial fibrillation
Reducing the incidence of atrial fibrillation by inhibiting angiotensin-converting enzyme
Dual antiplatelet therapy superior to monotherapy in reducing embolization in stroke patients
Fish oil supplements may lower cardiac risk by increasing heart rate variability
Expert panel: African Americans deserve greater statin access
Catheter ablation reduces AF recurrences
